Brochure
1 Oct 2020
ADCs Toxin and Conjugation CDMO Services
PDF 701 kB
Offered Services:
Content provided by our supplier
Cerbios-Pharma SA
-
CH -
2015On CPHI since
-
3Certificates
-
100 - 249Employees
Company types
Primary activities
Other Content from Cerbios-Pharma SA (4)
-
Brochure Cerbios FDF based on probiotic strain SF68
Cerbios own and manufactures the strain Enterococcus lactis SF68 applied in different therapeutic areas:
- Diarrhea, travellers diarrhea and dysbiosis: drug with 20 clinical trials, CTD dossier and registration from Switzerland (for extra EU Countries)
- Acne & Seborrheic dermatitis
- Obesity/Cholesterol and metabiolic syndrome
- IBS
- Immunity Booster
Any product is supported by precilical and clinical evidences.
Cerbios business model if B2B, searching for commercial Licensees worldwide
-
Brochure High Potency Active Ingredients CDMO Services
Cerbios is highly qualified in process development of new APIs and HPAPIs for preclinical, clinical and commercial supply. Cerbios is the ideal and reliable partner for your New Chemical Entity (NCE), NDA submission and commercial manufacturing. -
Brochure Cerbios offers high quality tailor-made programs for biopharmaceuticals
From cloning to cGMP production, Cerbios meets your product development and manufacturing needs for recombinant proteins, monoclonal antibodies (mAbs) and novel mAbs derivatives including fragments and Bispecific.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance